Macropinocytosis confers resistance to therapies targeting cancer anabolism
Macropinocytosis allows cancer cells to cope with nutrient stress. Here, the authors use a selective, genetic approach to inhibit macropinocytosis and show that consuming necrotic cell debris via macropinocytosis—necrocytosis—affords resistance to many therapies that target biosynthesis.
Guardado en:
Autores principales: | Vaishali Jayashankar, Aimee L. Edinger |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/737b7cdd758c4542bc38e47261135578 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Pharmacological inhibition of tumor anabolism and host catabolism as a cancer therapy
por: Alejandro Schcolnik-Cabrera, et al.
Publicado: (2021) -
Aerobic exercise intensity does not affect the anabolic signaling following resistance exercise in endurance athletes
por: T. W. Jones, et al.
Publicado: (2021) -
Compensatory anabolic signaling in the sarcopenia of experimental chronic arthritis
por: Robert D. Little, et al.
Publicado: (2017) -
ER stress induces anabolic resistance in muscle cells through PKB-induced blockade of mTORC1.
por: Louise Deldicque, et al.
Publicado: (2011) -
EZH2-mediated PP2A inactivation confers resistance to HER2-targeted breast cancer therapy
por: Yi Bao, et al.
Publicado: (2020)